ESOP22 Sept 2026, 04:50 pm
Eris Lifesciences allots 1,55,264 ESOP shares
AI Summary
Eris Lifesciences Ltd has announced the allotment of 1,55,264 equity shares on September 22, 2026, following the exercise of options under its ESOP Scheme. The shares were allotted from different grant years: 66,422 shares from the 2022 grant at ₹557.24 each, 57,239 shares from the 2023 grant at ₹510.32 each, and 31,603 shares from the 2024 grant at ₹728.16 each. Consequently, the company's paid-up share capital has increased from ₹13,85,83,305 to ₹13,87,38,569.
Key Highlights
- Eris Lifesciences allotted 1,55,264 equity shares under ESOP.
- Allotment occurred on September 22, 2026, from various grant years.
- Issue prices ranged from ₹510.32 to ₹728.16 per share.
- Paid-up share capital increased to ₹13,87,38,569.
- This allotment results in minor equity dilution.
Price Impact
More from ERIS